These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16139678

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Results of the European Glaucoma Prevention Study.
    Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I, European Glaucoma Prevention Study (EGPS) Group.
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [Abstract] [Full Text] [Related]

  • 3. A topical carbonic anhydrase inhibitor finally arrives.
    Palmberg P.
    Arch Ophthalmol; 1995 Aug; 113(8):985-6. PubMed ID: 7639673
    [No Abstract] [Full Text] [Related]

  • 4. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 5. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Stewart RM, Clearkin LG.
    Am J Ophthalmol; 2008 Jan; 145(1):182; author reply 182-3. PubMed ID: 18154757
    [No Abstract] [Full Text] [Related]

  • 6. Topical carbonic anhydrase inhibitors.
    Kass MA.
    Am J Ophthalmol; 1989 Mar 15; 107(3):280-2. PubMed ID: 2923154
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Glaucoma: an ocular blood flow disorder?].
    Recker K.
    Ophthalmologe; 2003 Feb 15; 100(2):2 p following 174. PubMed ID: 12650170
    [No Abstract] [Full Text] [Related]

  • 12. Additive effect of dorzolamide hydrochloride to patients taking travoprost: a retrospective study.
    Boyer S, Gay D.
    Optometry; 2008 Sep 15; 79(9):501-4. PubMed ID: 18722961
    [Abstract] [Full Text] [Related]

  • 13. MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.
    Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinreb RN, Skuta GL, Epstein DL, Shaw B, Holder DJ, Deasy DA.
    Ophthalmology; 1991 Mar 15; 98(3):308-12; discussion 312-3. PubMed ID: 2023750
    [Abstract] [Full Text] [Related]

  • 14. Switching from dorzolamide to brinzolamide: effect on intraocular pressure and patient comfort.
    Inoue K, Wada SA, Wakakura M, Inoue J, Tomita G.
    Jpn J Ophthalmol; 2006 Mar 15; 50(1):68-9. PubMed ID: 16453193
    [No Abstract] [Full Text] [Related]

  • 15. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R, Ticho U.
    Isr Med Assoc J; 2003 Apr 15; 5(4):260-3. PubMed ID: 14509130
    [Abstract] [Full Text] [Related]

  • 16. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
    Gafencu O, Armegioiu M, Ionita M.
    Oftalmologia; 1997 Apr 15; 41(1):66-8. PubMed ID: 9138500
    [Abstract] [Full Text] [Related]

  • 17. Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
    D'Andrea A, D'Andrea D, Ferreri G.
    Acta Ophthalmol Scand Suppl; 1998 Apr 15; (227):36-8. PubMed ID: 9972339
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Apr 15; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 19. Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
    Manni GL, Centofanti M, Napoli D, Parisi V, Bucci MG.
    Acta Ophthalmol Scand Suppl; 1997 Apr 15; (224):22-3. PubMed ID: 9589714
    [No Abstract] [Full Text] [Related]

  • 20. MK-927: a topically effective carbonic anhydrase inhibitor in patients.
    Bron AM, Lippa EA, Hofmann HM, Feicht BI, Royer JG, Brunner-Ferber FL, Panebianco DL, Von Denffer HA.
    Arch Ophthalmol; 1989 Aug 15; 107(8):1143-6. PubMed ID: 2667509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.